Trial: 202106025

A Phase 1, Multicenter, Single Agent Study to Evaluate the Safety,
Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor
Activity of CPO-100 in Adult Patients with Advanced Solid Tumors

Phase

I (Cancer Control)

Principal Investigator

Adkins, Douglas

Disease Site

Larynx; Lip, Oral Cavity and Pharynx

Learn more about this study at: clinicaltrials.gov